Stock Report

Neuland Laboratories Ltd Q4 FY2024 consolidated PAT falls to Rs. 67.56 crores

Posted On : 2024-05-11 09:44:38( TIMEZONE : IST )

Neuland Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2024.

Financial Results (Q4 FY2024) - QoQ Comparison

The company has reported total income of Rs. 390.3667 crores during the period ended March 31, 2024 as compared to Rs. 394.9289 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs. 67.5619 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 81.3902 crores for the period ended December 31, 2023.

The company has reported EPS of Rs. 52.66 for the period ended March 31, 2024 as compared to Rs. 63.44 for the period ended December 31, 2023.

Financials	Q4 FY2024	Q3 FY2024	% Change
Total Income	₹390.3667 crs	₹394.9289 crs	-1.16%
Net Profit	₹67.5619 crs	₹81.3902 crs	-16.99%
EPS	₹52.66	₹63.44	-16.99%

Financial Results (Q4 FY2024) - YoY Comparison

The company has reported total income of Rs.390.3667 crores during the period ended March 31, 2024 as compared to Rs.415.1368 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs.67.5619 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.84.5439 crores for the period ended March 31, 2023.

The company has reported EPS of Rs.52.66 for the period ended March 31, 2024 as compared to Rs.65.90 for the period ended March 31, 2023.

Financials	Q4 FY2024	Q4 FY2023	% Change
Total Income	₹390.3667 crs	₹415.1368 crs	-5.97%
Net Profit	₹67.5619 crs	₹84.5439 crs	-20.09%
EPS	₹52.66	₹65.90	-20.09%

Financial Results (Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.1571.1248 crores during the Financial Year ended March 31, 2024 as compared to Rs.1200.9462 crores during the Financial Year ended March 31, 2023.

The company has posted net profit / (loss) of Rs.300.0789 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.163.5176 crores for the Financial Year ended March 31, 2023.

The company has reported EPS of Rs.233.89 for the Financial Year ended March 31, 2024 as compared to Rs.127.45 for the Financial Year ended March 31, 2023.

Financials	Year Ended FY2024	Year Ended FY2023	% Change
Total Income	₹1571.1248 crs	₹1200.9462 crs	30.82%
Net Profit	₹300.0789 crs	₹163.5176 crs	83.51%
EPS	₹233.89	₹127.45	83.52%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 7447.45 as compared to the previous close of Rs. 7356.15. The total number of shares traded during the day was 1147 in over 428 trades.

The stock hit an intraday high of Rs. 7476.65 and intraday low of 7263.05. The net turnover during the day was Rs. 8519465.00.